Page last updated: 2024-08-24

acridine orange and Prostatic Neoplasms

acridine orange has been researched along with Prostatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JQ; Elfer, KN; Kimbrell, HZ; Lacey, M; Lee, BR; Schlichenmeyer, TC; Sholl, AB; Tulman, DB; Wang, M1
Liu, R; Tian, Z; Wang, J; Xu, Y; Zhang, Z1
Azizuddin, K; Berlin, J; Burda, C; Kenney, ME; Lam, M; Morris, RL; Nieminen, AL; Oleinick, NL; Samia, AC1
Isogawa, Y; Kakehi, Y; Kamoto, T; Kinoshita, H; Mizutani, Y; Ogawa, O; Terachi, T; Wu, XX1

Trials

1 trial(s) available for acridine orange and Prostatic Neoplasms

ArticleYear
High-Resolution Rapid Diagnostic Imaging of Whole Prostate Biopsies Using Video-Rate Fluorescence Structured Illumination Microscopy.
    Cancer research, 2015, Oct-01, Volume: 75, Issue:19

    Topics: Acridine Orange; Adenocarcinoma; Area Under Curve; Biopsy, Needle; Coloring Agents; Humans; Imaging, Three-Dimensional; Male; Microscopy, Fluorescence; Microscopy, Video; Observer Variation; Point-of-Care Systems; Predictive Value of Tests; Prostate; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; ROC Curve; Sensitivity and Specificity; Single-Blind Method; Time Factors

2015

Other Studies

3 other study(ies) available for acridine orange and Prostatic Neoplasms

ArticleYear
Evaluation of acridine orange fluorescence in exfoliative urinary cytology for diagnosing bladder carcinoma.
    International urology and nephrology, 2012, Volume: 44, Issue:5

    Topics: Acridine Orange; Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Coloring Agents; Cytodiagnosis; Eosine Yellowish-(YS); Female; Fluorescence; Fluorescent Dyes; Hematoxylin; Humans; Kidney Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Rosaniline Dyes; Sensitivity and Specificity; Staining and Labeling; Urinary Bladder Neoplasms; Urinary Calculi; Urine; Urothelium

2012
Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy.
    Cancer research, 2003, Sep-01, Volume: 63, Issue:17

    Topics: Acridine Orange; Binding Sites; Cardiolipins; Coloring Agents; Fluorescence Resonance Energy Transfer; Humans; Indoles; Male; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Spectrometry, Fluorescence; Subcellular Fractions; Tumor Cells, Cultured

2003
Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.
    International journal of oncology, 2002, Volume: 20, Issue:5

    Topics: Acridine Orange; Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Prostatic Neoplasms; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002